期刊文献+

RAGE和MMP-9在乳腺癌组织中的表达及临床相关性研究 被引量:6

Study on the expressions of RAGE and MMP- 9 in breast cancer and the clinical correlation
原文传递
导出
摘要 目的:探讨晚期糖基化终末产物受体(RAGE)及基质金属蛋白酶-9(MMP-9)在乳腺癌组织中的表达并分析其与临床相关病理因素的关系。方法:采用免疫组化法检测RAGE和MMP-9在60例乳腺癌组织及37例正常乳腺组织中的表达,并分析其与乳腺癌分化程度、浸润深度、淋巴结转移及TNM分期之间的关系。结果:RAGE及MMP-9在乳腺癌中的阳性表达率分别为70.00%和61.67%。乳腺癌病理分级、淋巴结转移与RAGE及MMP-9高表达密切相关(P<0.05),RAGE表达水平与MMP-9表达水平呈正相关(P<0.05)。结论:RAGE和MMP-9的表达水平可能与乳腺癌发生及转移密切相关,可作为乳腺癌药物治疗的重要靶点。 Objective: To explore the expressions of RAGE and MMP- 9 in breast cancer and the relationship with related clinicopathological factors. Methods: Immunohistochemical method was used to detect the expressions of RAGE and MMP- 9 in 60 cases with breast cancer and 37 cases with normal breast tissue. The relationship between RAGE and MMP- 9 expressions and differentiation degree,depth of invasion,lymph node metastasis,and TNM stage was analyzed. Results: The positive expression rates of RAGE and MMP- 9 in breast cancer were 70. 00% and 61. 67%,respectively; pathological grade and lymph node metastasis were closely correlated with high expressions of RAGE and MMP- 9( P 〈0. 05),RAGE expression level was positively correlated with MMP- 9 expression level( P〈 0. 05).Conclusion: The expression levels of RAGE and MMP- 9 may be closely correlated with occurrence and metastasis of breast cancer,which can be used as important targets for drug therapy of breast cancer.
出处 《中国妇幼保健》 CAS 2015年第16期2645-2648,共4页 Maternal and Child Health Care of China
基金 黑龙江省教育厅项目〔12541903〕
  • 相关文献

参考文献15

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2Ziegler RG, Anderson WF, Gail MH. Increasing breast cancer incidence in China: the numbers add up (J:. J Natl Cancer Inst, ,'2008, 100 (19): 1339-1341. 被引量:1
  • 3Logsdon CD, Fuentes MK, Huang EH, et al. RAGE and RAGE ligands in cancer [ J]. Curr Mol Med, 2007, 7 (8) : 777-789. 被引量:1
  • 4Radia AM, Yaser AM, Ma X, et al. Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines ( J l- Int J Mol Sci, 2013, 14 (4) : 7959-7978. 被引量:1
  • 5Zhu P, Ren M, Yang C, et al. Involvement of RAGE, MAPK and NF-:B pathways in ages-induced MMP-9 activation in HaCaT keratinocytes [ J ]. Exp Dermatol, 2012, 21 ( 2 ) : 123-129. 被引量:1
  • 6宋晓环,王忠超,朱莉,康淑红.基质金属蛋白酶-9在上皮性卵巢癌中的表达[J].中国妇幼保健,2014,29(7):1104-1106. 被引量:4
  • 7Zhang L, Bukulin M, Kojro E, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases [ J 3- J Biol Chem, 2008, 283 (51) : 35507-35516. 被引量:1
  • 8Zhang J, Zhu JS, Zhou Z, et al. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1- RAGE and Akt pathways in vitro and in vivo :J3. Oncol Rep, 2012, 27 (5) : 1511-1519. 被引量:1
  • 9Kuniyasu H, Oue N, Wakikawa A, et al. Expression of receptors for advanced glyeation end- products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer[J]. J Pathol, 2002, 196 (2) : 163-170. 被引量:1
  • 10Yamamoto K, Murata H, Putranto EW, et al. DOCK7 is a critical regulator of the RAGE- Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells [J]. Oncol Rep, 2013, 29 (3) : 1073-1079. 被引量:1

二级参考文献27

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4SHEU B C,LIEN H C,HO H N.Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer[J].Cancer Res,2003,63:6537-6542. 被引量:1
  • 5DRAGUTINOVIC V,IZRAEL-ZIVKOVIC L,RAD-OVANOVIC N.Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer[J].Dig Dis Sci,2009,54:1203-1207. 被引量:1
  • 6CHAUDHARY A K,SINGH M,BHARTI A C,et al.Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck[J].J Biomed Sci,2010,17:10-10. 被引量:1
  • 7OH J,TAKAHASHI R,KONDO S,et al.The membrane-anchored MMP inhibitor RECK is a key regulation of extracellular matrix integrity and angiogenesis[J].Cell,2001,107:789-800. 被引量:1
  • 8SIMIZU S,TAKAGI S,TAMURA Y,et al.RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines[J].Cancer Res,2005,65:7455-7461. 被引量:1
  • 9LOGSDON C D,FUENTES M K,HUANG E H,et al.RAGE and RAGE ligands in cancer[J].Curr Mol Med,2007,7:777-789. 被引量:1
  • 10HIRATA K,TADADA M,SUZUKI Y,et al.Expression of receptors for advanced glycation end products(RAGE)in human biliary cancer cells[J].Hepatogastroenterology,2003,50:1205-1207. 被引量:1

共引文献288

同被引文献47

  • 1Yip SC, Saha S, Chemoff J. PTP1B:a double agent in metabolism and oneogenesis[ J ]. Trends Bioehem Sei ,2010,35 (8) :442-449. 被引量:1
  • 2Revuelta-Cervarttes J, Mayoral R, Miranda S, et al. Protein tyro- sine phosphatase 1B (PTP1B) deficiency accelerates hepatic regen- eration in mice [J]. Am J Pathol, 2011, 178 (4) : 1591-1604. 被引量:1
  • 3Lessard L, Stuible M, Tremblay ML The two faces of PTP1B in cancer [J]. Biochim Biophys Acta, 2010, 1804 (3): 613-619. 被引量:1
  • 4Nishimura T. Total number of genome alterations in sporadic gastrein- testinal cancer inferred from pooled analyses in the literature [ J ]. Tumour Biol, 2008, 29 (6): 343-350. 被引量:1
  • 5Sun Y, Niu J, Huang J. Neuroendocrine differentiation in prostate cancer [J]. Am J Transl Res, 2009, 1 (2) : 148-162. 被引量:1
  • 6Wang J, Liu B, Chen X, et al. PTP1B expression contributes to gastric cancer progression [ J]. Med Onco1,2012,29 ( 2 ) :948-956. 被引量:1
  • 7Soysal S, Obermann EC, Gao F, et al. PTP1B expression is an in- dependent positive prognostic factor in human breast cancer [ J ]. Breast Cancer Res Treat, 2013, 137 (2) : 637-644. 被引量:1
  • 8Aceto N, Bentires-Alj M. Targeting pmtein-tyrosine phosphatases in breast cancer [J]. Oncotarget, 2012, 3 (5): 514-515. 被引量:1
  • 9Julien SG, Dub~ N, Read M, et al. Protein tyrosine phosphatasel B deficiency or inhibition delays ErbB2-induced mammary tumori- genesis and protects from lung metastasis [J]. Nat CJenet, 2007, 39 (3): 338-346. 被引量:1
  • 10Benti res-Alj M, Neel BG. Protein-tyrosine phosphataselB is re- quired for HER2/Neu-induced breast cancer [ J]. Cancer Res, 2007, 67 (6) : 2420-2424. 被引量:1

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部